Learn about our healthcare areas

Explore medicine and therapy products
Explore MedTech products

Find our latest news, stories and insights

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Catch up on the latest press releases and download media assets here

Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      1. Home/
      2. Media Center/
      3. Press releases /
      4. Innovative Medicine

      Innovative Medicine

      Innovative Medicine
      October 30, 2013

      New Marketing Authorisation Application Submitted to EMA for Ibrutinib for the Treatment of Two Forms of Blood Cancer

      The submission is for chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL) and mantle cell lymphoma (MCL), two difficult-to-treat diseases
      Learn more
      Innovative Medicine
      October 28, 2013

      New STELARA® Data Show Inhibition Of Joint Destruction In Patients With Active Psoriatic Arthritis

      Integrated Analysis of Two Pivotal Phase 3 Studies Showed STELARA Inhibited the Progression of Structural Damage at Week 24, and Demonstrated Continued Inhibition through Two Years
      Learn more
      Innovative Medicine
      October 28, 2013

      New Two-Year Results Show SIMPONI® ARIA™ (GOLIMUMAB) For Infusion Inhibited Radiographic Progression In Patients With Active Rheumatoid Arthritis

      Nearly 70 Percent of Patients Receiving SIMPONI ARIA at Two Years Demonstrated ACR 20 Response
      Learn more
      Innovative Medicine
      October 24, 2013

      FDA Advisory Committee Recommends Approval of Simeprevir for Combination Treatment of Genotype 1 Chronic Hepatitis C in Adult Patients

      Learn more
      Innovative Medicine
      October 15, 2013

      Janssen Submits Marketing Authorisation Application to European Medicines Agency for a Fixed-Dose Combination Tablet of HIV-1 Medicine Darunavir with Cobicistat

      Learn more
      Innovative Medicine
      October 8, 2013

      Janssen Acquires Investigational NS5A Inhibitor for the Treatment of Hepatitis C from GlaxoSmithKline

      Learn more
      Innovative Medicine
      October 7, 2013

      Simeprevir Data from COSMOS study in Hepatitis C Patients Accepted as Late-Breaking Presentation at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)

      Learn more
      Innovative Medicine
      October 1, 2013

      Simeprevir Data in Hepatitis C Patients to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)

      Learn more
      Innovative Medicine
      September 30, 2013

      New Study Shows Circulating Tumor Cell Enumeration – as Part of Composite Biomarker Panel –May Serve as a Surrogate for Efficacy Response in Metastatic Castration-Resistant Prostate Cancer

      First study to find patients with unfavorable risk profile at 12 weeks have worse prognosis and should be considered for alternative treatments
      Learn more
      Load More